Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01652326 · ClinicalTrials.gov registry record
Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 792
- Enrollment target
NCT01652326: Completed study, sponsored by University of Pittsburgh.
NCT01652326 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 792 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01652326 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 792 participants
- Enrollment target
Study Summary
The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.
Interventions
- DRUG Diazepam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 792 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-09 |
What the finished NCT01652326 record still lists
NCT01652326 is an observational study that tracks outcomes without assigning an intervention. The registered 792 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Diazepam is the first listed.
NCT01652326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01652326 about?
NCT01652326 is a clinical study titled "Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome". The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.
What is the current status of trial NCT01652326?
This trial is currently completed. The enrollment target is 792 participants. The study started on 2012-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01652326?
The interventions under investigation include: Diazepam (DRUG).
Who is sponsoring clinical trial NCT01652326?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03424005 · 792 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- NCT05866081 · 792 participants · NA
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
- NCT06722352 · 792 participants · NA
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
- NCT04967989 · 790 participants · Phase 3
Clarifying the Optimal Application of SLT Therapy Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia